Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000009

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jan 12, 2017
Accepted (ET)
Feb 28, 2017 · 7:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 12, 2017P1,000$0.0449A19,634,715D
Common StockJan 12, 2017P200$0.0449A19,634,915D
Common StockJan 12, 2017P534$0.045A19,635,449D
Common StockJan 12, 2017P200$0.0449A19,635,649D
Common StockJan 13, 2017P1,000$0.0496A19,636,649D
Common StockJan 13, 2017P1,000$0.0477A19,637,649D
Common StockJan 13, 2017P200$0.0441A19,637,849D
Common StockJan 13, 2017P200$0.0438A19,638,049D
Common StockJan 13, 2017P200$0.0451A19,638,249D
Common StockJan 13, 2017P100$0.0446A19,638,349D
Common StockJan 13, 2017P500$0.0446A19,638,849D
Common StockJan 13, 2017P200$0.0446A19,639,049D
Common StockJan 13, 2017P500$0.0445A19,639,549D
Common StockJan 13, 2017P500$0.0445A19,640,049D
Common StockJan 13, 2017P200$0.0446A19,640,249D
Common StockJan 13, 2017P200$0.0446A19,640,449D
Common StockJan 17, 2017P200$0.048A19,640,649D
Common StockJan 17, 2017P1,000$0.048A19,641,649D
Common StockJan 17, 2017P200$0.048A19,641,849D
Common StockJan 17, 2017P200$0.044A19,642,049D
Common StockJan 17, 2017P1,000$0.044A19,643,049D
Common StockJan 18, 2017P200$0.0419A19,643,249D
Common StockJan 18, 2017P500$0.0406A19,643,749D
Common StockJan 18, 2017P200$0.04A19,643,949D
Common StockJan 18, 2017P200$0.0388A19,644,149D
Common StockJan 19, 2017P100$0.0366A19,644,249D
Common StockJan 19, 2017P200$0.0369A19,644,449D
Common StockJan 19, 2017P200$0.0349A19,644,649D
Common StockJan 19, 2017P1,000$0.0349A19,645,649D
Common StockJan 19, 2017P1,000$0.0266A19,646,649D

Table II — derivative securities

No Table II lines on this filing.